Acknowledgements
Cancer
ONCOLOGY, LIVER, CANCER
We thank Servier for sharing the RECOURSE trial dataset and acknowledge all contributors to this trial. We thank the Hartwig Medical Foundation, the Center for Personalized Cancer Treatment and all participating centers for the generation of the discovery dataset. We thank the Memorial Sloan Cancer Center for generating the data used in this manuscript. We also thank the statistics department of the Netherlands Cancer Institute for support with the analyses and G. Arrivi and M. Roberto (Sant’Andrea Hospital Rome) for their support in data acquisition. We thank A. Bardelli and his team for sharing the isogenic SW48 models. E.E.V. and L.F.A.W. were supported by funding from the Oncode Institute. D.J.P. is supported by grant funding from the Wellcome Trust Strategic Fund (no. PS3416), the Foundation for Liver Research and the Associazione Italiana per la Ricerca sul Cancro (AIRC MFAG grant no. 25697); he acknowledges support from the National Institute for Health and Care Research (NIHR) Imperial Biomedical Research Centre, the Imperial Experimental Cancer Medicine Centre (ECMC) and the Imperial College Tissue Bank. N.V. was supported by Cancer Research UK (grant nos. A18052 and A26815), the NIHR Biomedical Research Centre at the Royal Marsden NHS Foundation Trust and the Institute of Cancer Research, the European Union FP7 (grant no. CIG 334261) and the Katherine and Douglas Longden Chair in Oncology at Imperial College London. N.V. also acknowledges infrastructural support from the ECMC at Imperial College London.